It’s time to register for the Hepatocyte Research Association (HRA) 11th Annual Meeting at ISSX Orlando: October 20, 2015 2pm – 6pm Hilton Orlando Bonnet Creek Floridian Ballroom G-I This year’s theme is “Next Generation Liver Culture Models: Applications for Industry.” Ajit Dash, Sylvie Klieber and Ed LeCluyse will talk on – Liver tissue engineering …
First-in-Human, Safety, Tolerability, PK and PD Study of a Rapid Onset Anesthetic: QPS Plays It Safe!
QPS was able to deliver on this extremely challenging early phase clinical trial because we have access to the expertise of a university anaesthesiology department in the Netherlands, and its associated facilities. See details below
Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients
Okay, we’ll admit it: a company telling you about their new brochure seems about as interesting as looking through your Great Uncle’s vacation pictures – for the tenth time. But we can’t help it. We’re really excited about this one! That’s because we’re proud to provide specialized, collaborative Clinical Development services that help us build …
Writing the Book on Beta-Alanine for Sports Performance: QPS MRA’s Doug Kalman Takes a Stand
Ever wish that really big hill you always cycle up would seem a little less hilly? Want to swing impressive poundage at your next kettlebell class?According to Doug Kalman PhD, RD, Director of Nutrition & Endocrinology at QPS MRA (Miami Research Associates) and other contributors to the International Society of Sports Nutrition’s position paper on …
QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients
Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a multi-layered, slow-release cannabinoid chewing gum. Not for the candy stand, MedChewRx® is seeking FDA and EMA approval for the treatment of pain and spasticity associated with multiple sclerosis. Characteristically, QPS is …
Mental Vacation
Need a vacation? Don’t have time? Spend the next 45 seconds pretending you’re here.
Sports Nutrition Leadership, Benchtop to Countertop: Watch the Webinar on Building Better Beverages with panelist Doug Kalman, Director of Nutrition & Endocrinology at QPS MRA
Finding something tasty to drink at the mini-mart has gotten really complicated lately. Knowing the usual soft drinks are unhealthy, you may be tempted by the “sport” drink section. But even if you’ve grabbed the colorless option to avoid massive quantities of Blue #1 or Yellow #5, a quick label-read may have you flipping that …
Fast Track Routes for Medicines that address Unmet Medical Needs
Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorization The European Medicines Agency (EMA) has revised its guidelines on the implementation of accelerated assessment and conditional marketing authorization, two key tools in the European legislation to accelerate patients’ access to medicines that address unmet medical needs. Accelerated assessment and …
DMPK scientists from Exelixis and QPS publish on “Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites” in DMD
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD). Cabozantinib (COMETRIQ®) inhibits the activity of tyrosine kinases including MET, VEGFRs and RET. These receptor tyrosine kinases are involved in both normal cellular function and in pathologic processes such as oncogenesis, metastasis, tumor angiogenesis, and maintenance of the tumor microenvironment. Cabozantinib is currently approved …
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work significantly better than the rest (if at all.) Imagine the excitement, then, at finding that an agent already prescribed for diabetes really can help patients lose significant amounts of weight. And …
